Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -4.90 is 42% above its 3-year average of -8.41, near the high end of its 3-year range (-9.63–-4.90).
36.24% above its 12-month average of -7.69.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.14.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 11 comparable quarters.
EARNINGS PER SHARE (EPS)
-4.90
EARNINGS PER SHARE (EPS) AVG TTM
-7.69
EARNINGS PER SHARE (EPS) AVG 3Y
-8.41
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+36.24%
CURRENT VS 3Y AVG
+41.77%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.67M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
N/A
Market Cap
$3.70M
Earnings Per Share (EPS)
N/A
TTM Avg
-37.01
3Y Avg
-21.04
5Y Avg
-1.64
Market Cap
$3.77M
Earnings Per Share (EPS)
-18.85
TTM Avg
-47.63
3Y Avg
-99.69
5Y Avg
-316.96
Market Cap
$3.56M
Earnings Per Share (EPS)
-14.40
TTM Avg
-19.95
3Y Avg
-16.43
5Y Avg
-17.45
Market Cap
$3.79M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$3.49M
Earnings Per Share (EPS)
-0.45
TTM Avg
-1.48
3Y Avg
-5.05
5Y Avg
-8.12
Market Cap
$3.87M
Earnings Per Share (EPS)
-6.05
TTM Avg
-42.97
3Y Avg
-23.50
5Y Avg
-16.51
Market Cap
$3.46M
Earnings Per Share (EPS)
N/A
TTM Avg
-130.80
3Y Avg
-71.47
5Y Avg
-57.18
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.67M | -4.90 | -7.69 | -8.41 | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.70M | N/A | -37.01 | -21.04 | -1.64 |
| Eocene Ltd. (EOCN)vs › | $3.58M | N/A | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.77M | -18.85 | -47.63 | -99.69 | -316.96 |
| Nexalin Technology, Inc. (NXL)vs › | $3.56M | -14.40 | -19.95 | -16.43 | -17.45 |
| Evogene Ltd. (EVGN)vs › | $3.79M | -0.91 | -1.99 | -3.92 | -2.83 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -0.45 | -1.48 | -5.05 | -8.12 |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.87M | -6.05 | -42.97 | -23.50 | -16.51 |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A | -130.80 | -71.47 | -57.18 |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.96M | -211.18 | -432751.00 | -875189.50 | -22462429.83 |
Trailing EPS (TTM)
$-4.90
Forward EPS (Est.)
$-3.86
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -6.64 |
| 2024-12-31 | -8.73 |
| 2023-12-31 | -9.63 |
| 2022-12-31 | -8.66 |
